Literature DB >> 27698066

Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.

Christopher T Banek1, Mark M Knuepfer1, Jason D Foss1, Jessica K Fiege1, Ninitha Asirvatham-Jeyaraj1, Dusty Van Helden1, Yoji Shimizu1, John W Osborn2.   

Abstract

Renal sympathetic denervation (RDNx) has emerged as a novel therapy for hypertension; however, the therapeutic mechanisms remain unclear. Efferent renal sympathetic nerve activity has recently been implicated in trafficking renal inflammatory immune cells and inflammatory chemokine and cytokine release. Several of these inflammatory mediators are known to activate or sensitize afferent nerves. This study aimed to elucidate the roles of efferent and afferent renal nerves in renal inflammation and hypertension in the deoxycorticosterone acetate (DOCA) salt rat model. Uninephrectomized male Sprague-Dawley rats (275-300 g) underwent afferent-selective RDNx (n=10), total RDNx (n=10), or Sham (n=10) and were instrumented for the measurement of mean arterial pressure and heart rate by radiotelemetry. Rats received 100-mg DOCA (SC) and 0.9% saline for 21 days. Resting afferent renal nerve activity in DOCA and vehicle animals was measured after the treatment protocol. Renal tissue inflammation was assessed by renal cytokine content and T-cell infiltration and activation. Resting afferent renal nerve activity, expressed as a percent of peak afferent nerve activity, was substantially increased in DOCA than in vehicle (35.8±4.4 versus 15.3±2.8 %Amax). The DOCA-Sham hypertension (132±12 mm Hg) was attenuated by ≈50% in both total RDNx (111±8 mm Hg) and afferent-selective RDNx (117±5 mm Hg) groups. Renal inflammation induced by DOCA salt was attenuated by total RDNx and unaffected by afferent-selective RDNx. These data suggest that afferent renal nerve activity may mediate the hypertensive response to DOCA salt, but inflammation may be mediated primarily by efferent renal sympathetic nerve activity. Also, resting afferent renal nerve activity is elevated in DOCA salt rats, which may highlight a crucial neural mechanism in the development and maintenance of hypertension.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  afferent neurons; arterial pressure; denervation; deoxycorticosterone acetate; hypertension; inflammation

Mesh:

Substances:

Year:  2016        PMID: 27698066      PMCID: PMC5159336          DOI: 10.1161/HYPERTENSIONAHA.116.07850

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

1.  Autonomic renal denervation ameliorates experimental glomerulonephritis.

Authors:  Roland Veelken; Eva-Maria Vogel; Karl Hilgers; Kerstin Amann; Andrea Hartner; Gabriele Sass; Winfried Neuhuber; Gisa Tiegs
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

2.  Age-dependent changes in afferent renal nerve activity in genetically hypertensive rats.

Authors:  N G Moss; A B Scoltock
Journal:  Am J Physiol       Date:  1992-05

3.  A limited renal injury may cause a permanent form of neurogenic hypertension.

Authors:  S Ye; M Gamburd; P Mozayeni; M Koss; V M Campese
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

4.  Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.

Authors:  Dagmara Hering; Petra Marusic; Antony S Walton; Elisabeth A Lambert; Henry Krum; Krzysztof Narkiewicz; Gavin W Lambert; Murray D Esler; Markus P Schlaich
Journal:  Hypertension       Date:  2014-04-14       Impact factor: 10.190

5.  Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.

Authors:  Steffen Desch; Thomas Okon; Diana Heinemann; Konrad Kulle; Karoline Röhnert; Melanie Sonnabend; Martin Petzold; Ulrike Müller; Gerhard Schuler; Ingo Eitel; Holger Thiele; Philipp Lurz
Journal:  Hypertension       Date:  2015-03-30       Impact factor: 10.190

6.  Effect of afferent renal nerve stimulation on blood pressure, heart rate and noradrenergic activity in conscious rats.

Authors:  K P Patel; M M Knuepfer
Journal:  J Auton Nerv Syst       Date:  1986-10

7.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

8.  Afferent renal nerve effects on plasma vasopressin and oxytocin in conscious rats.

Authors:  J K Simon; N W Kasting; J Ciriello
Journal:  Am J Physiol       Date:  1989-06

9.  Sensory denervation of the kidney attenuates renovascular hypertension in the rat.

Authors:  J M Wyss; N Aboukarsh; S Oparil
Journal:  Am J Physiol       Date:  1986-01

10.  Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience.

Authors:  Evgeny Pokushalov; Alexander Romanov; Demosthenes G Katritsis; Sergey Artyomenko; Sevda Bayramova; Denis Losik; Vera Baranova; Alexander Karaskov; Jonathan S Steinberg
Journal:  Heart Rhythm       Date:  2014-03-29       Impact factor: 6.343

View more
  45 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

2.  Renal denervation and CD161a immune ablation prevent cholinergic hypertension and renal sodium retention.

Authors:  Nandita Raikwar; Cameron Braverman; Peter M Snyder; Robert A Fenton; David K Meyerholz; Francois M Abboud; Sailesh C Harwani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-07       Impact factor: 4.733

Review 3.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

4.  Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.

Authors:  Christopher T Banek; Madeline M Gauthier; Daniel C Baumann; Dusty Van Helden; Ninitha Asirvatham-Jeyaraj; Angela Panoskaltsis-Mortari; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-07       Impact factor: 3.619

Review 5.  Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation.

Authors:  John W Osborn; Christopher T Banek
Journal:  Hypertension       Date:  2018-01-02       Impact factor: 10.190

Review 6.  Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex.

Authors:  Carolina Dalmasso; Jacqueline R Leachman; Jeffrey L Osborn; Analia S Loria
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-23       Impact factor: 3.619

Review 7.  Inflammatory macrophages in the kidney contribute to salt-sensitive hypertension.

Authors:  Daniel J Fehrenbach; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

Review 8.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.

Authors:  Leon J DeLalio; Alan F Sved; Sean D Stocker
Journal:  Can J Cardiol       Date:  2020-03-06       Impact factor: 5.223

9.  Amplification of Salt-Sensitive Hypertension and Kidney Damage by Immune Mechanisms.

Authors:  David L Mattson; John Henry Dasinger; Justine M Abais-Battad
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 2.689

10.  Renal nerves and leukocyte infiltration in the kidney during salt-sensitive hypertension.

Authors:  Ammar J Alsheikh; Hayley Lund; John Henry Dasinger; Justine M Abais-Battad; Daniel J Fehrenbach; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-05       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.